CSNK1G3 Human Pre-designed siRNA Set A contains three designed siRNAs for CSNK1G3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSNK2A1 Human Pre-designed siRNA Set A contains three designed siRNAs for CSNK2A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSNK2A2 Human Pre-designed siRNA Set A contains three designed siRNAs for CSNK2A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSNK2B Human Pre-designed siRNA Set A contains three designed siRNAs for CSNK2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSPG4 Human Pre-designed siRNA Set A contains three designed siRNAs for CSPG4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSPG5 Human Pre-designed siRNA Set A contains three designed siRNAs for CSPG5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSPP1 Human Pre-designed siRNA Set A contains three designed siRNAs for CSPP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSRNP1 Human Pre-designed siRNA Set A contains three designed siRNAs for CSRNP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSRP1 Human Pre-designed siRNA Set A contains three designed siRNAs for CSRP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSRP2 Human Pre-designed siRNA Set A contains three designed siRNAs for CSRP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSRP3 Human Pre-designed siRNA Set A contains three designed siRNAs for CSRP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CST1 Human Pre-designed siRNA Set A contains three designed siRNAs for CST1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CST11 Human Pre-designed siRNA Set A contains three designed siRNAs for CST11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CST2 Human Pre-designed siRNA Set A contains three designed siRNAs for CST2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CST3 Human Pre-designed siRNA Set A contains three designed siRNAs for CST3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CST4 Human Pre-designed siRNA Set A contains three designed siRNAs for CST4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CST5 Human Pre-designed siRNA Set A contains three designed siRNAs for CST5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CST6 Human Pre-designed siRNA Set A contains three designed siRNAs for CST6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CST7 Human Pre-designed siRNA Set A contains three designed siRNAs for CST7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CST8 Human Pre-designed siRNA Set A contains three designed siRNAs for CST8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CST9 Human Pre-designed siRNA Set A contains three designed siRNAs for CST9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CST967 (Compound 17) is a USP7 PROTAC degrader, and increasing the PROTAC concentration can enhance the degradation rate of USP7. CST967 can be used in cancer research[1].

CST967 (Compound 17) is a USP7 PROTAC degrader, and increasing the PROTAC concentration can enhance the degradation rate of USP7. CST967 can be used in cancer research[1].

CST967 (Compound 17) is a USP7 PROTAC degrader, and increasing the PROTAC concentration can enhance the degradation rate of USP7. CST967 can be used in cancer research[1].

CST967 (Compound 17) is a USP7 PROTAC degrader, and increasing the PROTAC concentration can enhance the degradation rate of USP7. CST967 can be used in cancer research[1].

CSTA Human Pre-designed siRNA Set A contains three designed siRNAs for CSTA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSTB Human Pre-designed siRNA Set A contains three designed siRNAs for CSTB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSTF1 Human Pre-designed siRNA Set A contains three designed siRNAs for CSTF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSTF2 Human Pre-designed siRNA Set A contains three designed siRNAs for CSTF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSTF2T Human Pre-designed siRNA Set A contains three designed siRNAs for CSTF2T gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CSTF3 Human Pre-designed siRNA Set A contains three designed siRNAs for CSTF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CT45A1 Human Pre-designed siRNA Set A contains three designed siRNAs for CT45A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CT55 Human Pre-designed siRNA Set A contains three designed siRNAs for CT55 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CT83 Human Pre-designed siRNA Set A contains three designed siRNAs for CT83 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CTAG1A Human Pre-designed siRNA Set A contains three designed siRNAs for CTAG1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CTAG1B Human Pre-designed siRNA Set A contains three designed siRNAs for CTAG1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CTAG2 Human Pre-designed siRNA Set A contains three designed siRNAs for CTAG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CTBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for CTBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CTBP2 Human Pre-designed siRNA Set A contains three designed siRNAs for CTBP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CTBS Human Pre-designed siRNA Set A contains three designed siRNAs for CTBS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CTC1 Human Pre-designed siRNA Set A contains three designed siRNAs for CTC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CTCF Human Pre-designed siRNA Set A contains three designed siRNAs for CTCF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CTCFL Human Pre-designed siRNA Set A contains three designed siRNAs for CTCFL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CTDNEP1 Human Pre-designed siRNA Set A contains three designed siRNAs for CTDNEP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CTDP1 Human Pre-designed siRNA Set A contains three designed siRNAs for CTDP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.